Related Experiment Video
Updated: Mar 20, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Impact of donor age on cardiac transplantation outcomes and on cardiac function
Themistokles Chamogeorgakis1, Susie Joseph2, Shelley Hall2
1Department of Thoracic and Cardiac Surgery, Baylor University Medical Center at Dallas, Dallas, TX, USA themistokles.chamogeorgakis@baylorhealth.edu.
Insights
Using hearts from donors over 50 years old for heart transplantation does not negatively impact survival or graft function. Careful donor selection ensures comparable outcomes, allowing expanded use of older donor hearts.
Area of Science:
- Cardiology
- Transplant Surgery
- Geriatric Medicine
Background:
- Conflicting data exists regarding the impact of older donor age on heart transplant outcomes.
- Previous studies have not definitively established survival results for older donor heart transplants.
Purpose of the Study:
- To analyze the impact of older donor age on heart transplant survival and myocardial function.
- To compare transplant outcomes between younger and older donor groups.
Main Methods:
- Retrospective review of heart transplant recipients at Baylor University Medical Center (Nov 2012-Mar 2015).
- Division of recipients into two groups based on donor age (≥50 years vs. <50 years).
- Comparison of in-hospital/1-year survival, rejection, graft dysfunction, inotropic score, ejection fraction, and length of stay.
Main Results:
- No significant difference in in-hospital or 1-year survival between older and younger donor groups.
- Older donors had a higher incidence of death due to intracranial bleeding (48.1%) versus anoxia (43.9%) in younger donors.
- No increased risk of graft dysfunction, higher inotropic support, longer hospital stays, or severe rejection episodes with older donors.
Conclusions:
- Heart transplantation from carefully selected donors over 50 years old is not associated with reduced survival or impaired graft function.
- The use of hearts from donors >50 years can be safely expanded to carefully selected recipients, not just critically ill ones.
Objectives:
Although the impact of older donors on heart transplant outcomes has been previously published, the survival results are conflicting. We herein analyse the impact of older donors on transplant survival and myocardial function.
Methods:
The records of the patients who underwent heart transplant at Baylor University Medical Center at Dallas from November 2012 until March 2015 were reviewed and the data were extracted. The heart recipients were divided into two groups based on donors age; 50 years of age was the division point. The two groups were compared with regard to the following transplant outcomes: in-hospital and 1-year survival, severe (3R) rejection, primary graft dysfunction, myocardial performance as reflected by the inotropic score, left ventricular ejection fraction, intensive care unit and overall length of stay.
Results:
Anoxia was more common cause of death in younger donors (43.9%), whereas intracranial bleeding was more frequent in older donors (48.1%, P = 0.016). The in-hospital survival and 1-year survival were the same between the two groups. Additionally, cardiac transplantation from older donors was not associated with higher incidence of graft dysfunction, higher inotropic support score, longer intensive care unit and total hospital length of stay or more frequent severe rejection episodes. The left ventricular ejection fraction was similar between the two groups.
Conclusions:
Heart transplant from older donors is not associated with lower in-hospital and mid-term survival if donors are carefully selected; furthermore, the graft function is comparable. The use of hearts from donors older than 50 years of age can be expanded beyond critically ill recipients in carefully selected recipients.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

